These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1582327

  • 1. Lung disease associated with orally administered mesalamine for ulcerative colitis.
    Reinoso MA, Schroeder KW, Pisani RJ.
    Chest; 1992 May; 101(5):1469-71. PubMed ID: 1582327
    [Abstract] [Full Text] [Related]

  • 2. Mesalamine-induced lung toxicity.
    Bitton A, Peppercorn MA, Hanrahan JP, Upton MP.
    Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
    [Abstract] [Full Text] [Related]

  • 3. Oral mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1992 Aug 21; 34(877):80-1. PubMed ID: 1353858
    [No Abstract] [Full Text] [Related]

  • 4. [Acute alveolitis in ulcerative colitis: extra-intestinal organ complication or drug side effect].
    Hesselmann J, Kuhn M, Ostendorf PC, Huep WW.
    Leber Magen Darm; 1991 Jan 21; 21(1):26-8, 31. PubMed ID: 2027303
    [Abstract] [Full Text] [Related]

  • 5. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L, Cohen H, Dooley C, Rubin P, Orchard J.
    Am J Gastroenterol; 1996 Jul 21; 91(7):1338-42. PubMed ID: 8677990
    [Abstract] [Full Text] [Related]

  • 6. Mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1988 May 20; 30(766):53-4. PubMed ID: 3283508
    [No Abstract] [Full Text] [Related]

  • 7. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS, Riff DS, Pruitt R, Wruble L, Koval G, Sales D, Bell JK, Johnson LK.
    Am J Gastroenterol; 2002 Jun 20; 97(6):1398-407. PubMed ID: 12094857
    [Abstract] [Full Text] [Related]

  • 8. Oral balsalazide (Colazal) for ulcerative colitis.
    Med Lett Drugs Ther; 2001 Jul 23; 43(1109):62-3. PubMed ID: 11468602
    [No Abstract] [Full Text] [Related]

  • 9. [Mesalazine (5-ASA) in ulcerative colitis].
    Dybdahl JH.
    Tidsskr Nor Laegeforen; 1990 Oct 10; 110(24):3130-1. PubMed ID: 2237871
    [No Abstract] [Full Text] [Related]

  • 10. [Pulmonary complications in patient with ulcerative colitis, treated with 5-aminosalicylic preparations].
    Radwan P, łupina T, Radwan-Kwiatek K, Milanowski J.
    Pneumonol Alergol Pol; 2006 Oct 10; 74(2):224-6. PubMed ID: 17269374
    [Abstract] [Full Text] [Related]

  • 11. Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.
    Drug Ther Bull; 1992 Jun 22; 30(13):50-2. PubMed ID: 1628539
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A case of mesalazine-induced lung injury improved by only discontinuation of mesalazine].
    Shimizu T, Hayashi M, Shimizu N, Kinebuchi S, Toyama J.
    Nihon Kokyuki Gakkai Zasshi; 2009 Jun 22; 47(6):543-7. PubMed ID: 19601534
    [Abstract] [Full Text] [Related]

  • 14. Exacerbation of chronic ulcerative colitis with mesalamine.
    Sturgeon JB, Bhatia P, Hermens D, Miner PB.
    Gastroenterology; 1995 Jun 22; 108(6):1889-93. PubMed ID: 7768395
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G, Carrai M, Venturini G, Gambardella L.
    Minerva Dietol Gastroenterol; 1990 Jun 22; 36(1):31-3. PubMed ID: 1970855
    [Abstract] [Full Text] [Related]

  • 17. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
    Barber GB, Lee DE, Antonioli DA, Peppercorn MA.
    Am J Gastroenterol; 1985 Aug 22; 80(8):612-4. PubMed ID: 2862789
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
    Dew MJ, Hughes P, Harries AD, Williams G, Evans BK, Rhodes J.
    Br Med J (Clin Res Ed); 1982 Oct 09; 285(6347):1012. PubMed ID: 6127137
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.